Ccl25 - chemokine (C-C motif) ligand 25 Gene

Also Known as TECK; CKb15; Scya25; A130072A22Rik

Species: Mus musculus

Gene Type: protein coding
Gene ID: 20300

Summary

Enables chemokine activity. Acts upstream of or within chemotaxis and leukocyte migration. Predicted to be located in extracellular region. Predicted to be active in extracellular space. Is expressed in 3rd branchial pouch; central nervous system; hemolymphoid system; retina; and thymus/parathyroid primordium. Orthologous to human CCL25 (C-C motif chemokine ligand 25). [provided by Alliance of Genome Resources, Apr 2022]

Ccl25 Products (1)

mRNA Protein Name
NM_009138.3 NP_033164.1 C-C motif chemokine 25 precursor

Gene Ontology

  • Molecular Function
  • Biological Process
Molecular Function GO Annotation Evidence References Source
enables chemokine activity IDA
IDA: Inferred from direct assay
10623805 MGI
enables protein binding IPI
IPI: Inferred from physical interaction
10623805 MGI
Biological Process GO Annotation Evidence References Source
acts upstream of or within chemotaxis IDA
IDA: Inferred from direct assay
10623805 MGI
acts upstream of or within leukocyte migration IDA
IDA: Inferred from direct assay
15358618 MGI
acts upstream of or within lymphoid lineage cell migration IDA
IDA: Inferred from direct assay
15358618 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

C-C motif chemokine 25

  • small inducible chemokine 25

  • small inducible cytokine A25

  • thymus-expressed chemokine

Recombinant Ccl25 Proteins

Cat. No. Product Name Accession Purity
HY-P71893 TECK/CCL25 Protein, Mouse O35903 (Q24-N144) ≥ 95%, as determined by reducing SDS-PAGE.

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Phase
HY-15724 Vercirnon Antagonist 98.01% Phase 3
HY-123763 MLN3126 Antagonist 98.02% Phase 1

Pre-clinical Phase

Bioactive Molecules (5)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-15724A Vercirnon sodium Antagonist 98.04% Unkown
HY-RS02095 CCL25 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-174757 Human CCL25 mRNA / Unkown
HY-RS17131 Ccl25 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23576 Ccl25 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
Inhibitory Antibodies (1)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P991168 Velaprumig Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Ccl25 NCBI NCBI:6370